Use of the Hypertensive Agent Angiotensin Ii for Modifying Oxygen Delivery to Tumours
Ischaemia-induced tumour hypoxia can limit the effectiveness of radiotherapy. Regions of deficient blood flow within tumours also limit the access of blood-borne anti-cancer agents. Vasoconstrictor drugs, such as angiotensin II, have potential for improving the oxygen status of tumours via an increase in their blood flow. This would occur if the tumour perfusion pressure could be increased without increasing tumour vascular resistance. An increase in absolute tumour blood flow following i.v. infusion of angiotensin II has been reported in the literature (Hori et al.,1991,Tanda et al.,1991,Tokuda et al.,1990).The aims of this study were 1) to determine the relationship between blood flow response to angiotensin II and perfusion pressure and 2) to investigate whether angiotensin II induces any improvement in blood flow to very poorly perfused tumour regions which are critical for the outcome of both radiotherapy and chemotherapy.
KeywordsCatheter Polyethylene Angiotensin Convolution Eosin
Unable to display preview. Download preview PDF.
- Brown, J. M. Exploitation of bioreductive agents with vasoactive drugs, in: “Proc. 8th International Congress of Radiation Research, Edinburgh, U.K., 1987” Taylor & Francis, London. Vol. 2, p 719.Google Scholar
- Hirst, D.G. & Tozer, G.M., 1992, Pharmacological manipulation of blood flow, Br. J. Radiol., in press Google Scholar
- Hori, K., Suzuki, M., Tanda, S., Saito, S., Shinozaki, M. & Zhang, Q.H., 1991, Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension, Jpn. J. Cancer Res.82:0..Google Scholar
- Kety, S.S., 1960, Theory of blood tissue exchange and its application to measurements of blood flow, Methods Med. Res. 8:223.Google Scholar
- Kobayashi, H., Hasuda, K., Taniguchi, S. & Baba, T., 1991, Therapeutic efficacy of two-route chemotherapy using cis-diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, combined with the angiotensin-Il-induced hypertension method in a rat uterine tumor, Int. J. Cancer 47:893.PubMedCrossRefGoogle Scholar
- Less, J.R., Possner, M.C., Boucher, Y., Wolmark, N. & Jain, R.K., 1991, Elevated interstitial fluid pressure in human tumors, Pro. Am. Assoc. Cancer Res. 32:59.Google Scholar
- Noguchi, S., Miyachi,K., Nishizawa, Y., Sasaki, Y., Imaoka, S., Iwanaga, T., Koyama, H. and Terasawa, T., 1988, Augmentation of anti-cancer effect with angiotensin II in intra-arterial infusion chemotherapy for breast carcinoma, Cancer 62:467.Google Scholar
- Sasaki, Y., Imaoka, S., Hasegawa, Y., Nakano, S., Ishikawa, O., Ohigashi, H., Taniguchi, K., Koyama, H., Iwanaga, T. and Terasawa, T., 1985, Changes in distribution of hepatic blood flow induced by intraarterial infusion of angiotensin II in human hepatic cancer, Cancer 55:311.PubMedCrossRefGoogle Scholar
- Tozer, G.M. & Shaffi, K. M., 1992, Modification of tumour blood flow using the hypertensive agent, angiotensin II, Submitted to Br. J. Cancer.Google Scholar